Urpilainen E, et al. - Researchers performed a retrospective cohort study to evaluate the prognosis of ovarian cancer in women with type 2 diabetes (T2D) treated with metformin, other forms of antidiabetic medication, or statins. Participants in the study were women with T2D diagnosed with ovarian cancer in Finland 1998–2011. This study yielded no conclusive evidence indicating any differences in mortality from ovarian cancer or other causes between different antidiabetic medication groups. Some evidence of improved prognosis of ovarian cancer with pre-diagnostic statin use was found.